New blood analysis capable of early detection of cancer tumors
New blood analysis capable of early detection of cancer tumors
WASHINGTON (Reuters) - US researchers at Johns Hopkins University have tested a new blood test called CANCER SEEK, which is capable of detecting cancer tumors early through DNA and blood cancer, and has yielded positive results in 70 percent of eight cancers in more than 1,000 patients.
The cancer is caused by changes in DNA in the cells of the body, in addition to the ability to reproduce outside the control of the immune system, and the large number of adults need cells from 20 to 30 years to spread in the body component of what is known as change the status of disease and development of the tumor to Advanced stage.
Most cases are treated only by surgery. Cancer cells at the time of their death spread parts of their DNA, so researchers were able to test for 16 genes and eight proteins, and to identify the primary organ that had cancer before it spread.
About 1005 non-proliferative cancer patients were tested in the first to third stages of ovaries, liver, stomach, pancreas, larynx, lung, breast and colon. The incidence was 69 to 98 percent.
The test is currently being tested on a blood sample of women volunteers between the ages of 65 and 75 who have not had cancer before. The study targets 50,000 women, costing $ 50 million over five years.
New blood analysis capable of early detection of cancer tumors
WASHINGTON (Reuters) - US researchers at Johns Hopkins University have tested a new blood test called CANCER SEEK, which is capable of detecting cancer tumors early through DNA and blood cancer, and has yielded positive results in 70 percent of eight cancers in more than 1,000 patients.
The cancer is caused by changes in DNA in the cells of the body, in addition to the ability to reproduce outside the control of the immune system, and the large number of adults need cells from 20 to 30 years to spread in the body component of what is known as change the status of disease and development of the tumor to Advanced stage.
Most cases are treated only by surgery. Cancer cells at the time of their death spread parts of their DNA, so researchers were able to test for 16 genes and eight proteins, and to identify the primary organ that had cancer before it spread.
About 1005 non-proliferative cancer patients were tested in the first to third stages of ovaries, liver, stomach, pancreas, larynx, lung, breast and colon. The incidence was 69 to 98 percent.
The test is currently being tested on a blood sample of women volunteers between the ages of 65 and 75 who have not had cancer before. The study targets 50,000 women, costing $ 50 million over five years.